IS7306A - Lyfjasamsetningar taxanafleiðna, virkar eftir inntöku um munn, og sem eru með aukna líffræðilega virkni - Google Patents
Lyfjasamsetningar taxanafleiðna, virkar eftir inntöku um munn, og sem eru með aukna líffræðilega virkniInfo
- Publication number
- IS7306A IS7306A IS7306A IS7306A IS7306A IS 7306 A IS7306 A IS 7306A IS 7306 A IS7306 A IS 7306A IS 7306 A IS7306 A IS 7306A IS 7306 A IS7306 A IS 7306A
- Authority
- IS
- Iceland
- Prior art keywords
- pharmaceutical compositions
- biological activity
- increased biological
- taxane derivatives
- oral taxane
- Prior art date
Links
- 230000004071 biological effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34288901P | 2001-12-20 | 2001-12-20 | |
| PCT/US2002/040127 WO2003053350A2 (en) | 2001-12-20 | 2002-12-12 | Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7306A true IS7306A (is) | 2004-06-10 |
Family
ID=23343716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7306A IS7306A (is) | 2001-12-20 | 2004-06-10 | Lyfjasamsetningar taxanafleiðna, virkar eftir inntöku um munn, og sem eru með aukna líffræðilega virkni |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20030220391A1 (is) |
| EP (1) | EP1465618A2 (is) |
| JP (1) | JP2006501134A (is) |
| KR (1) | KR20040066921A (is) |
| CN (1) | CN1273130C (is) |
| AR (1) | AR037951A1 (is) |
| AU (1) | AU2002361701A1 (is) |
| BR (1) | BR0215184A (is) |
| CA (1) | CA2470826A1 (is) |
| GE (1) | GEP20063806B (is) |
| HR (1) | HRP20040545A2 (is) |
| HU (1) | HUP0500843A2 (is) |
| IL (1) | IL162118A0 (is) |
| IS (1) | IS7306A (is) |
| MX (1) | MXPA04005877A (is) |
| NO (1) | NO20043101L (is) |
| PE (1) | PE20030742A1 (is) |
| PL (1) | PL374283A1 (is) |
| RS (1) | RS52904A (is) |
| RU (1) | RU2004119557A (is) |
| TW (1) | TW200302086A (is) |
| UY (1) | UY27598A1 (is) |
| WO (1) | WO2003053350A2 (is) |
| ZA (1) | ZA200404584B (is) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005519075A (ja) * | 2002-02-25 | 2005-06-30 | リフジャスロウン エイチエフ | 吸収促進剤 |
| US6855332B2 (en) * | 2002-07-03 | 2005-02-15 | Lyfjathroun Hf. | Absorption promoting agent |
| KR100533458B1 (ko) | 2002-07-20 | 2005-12-07 | 대화제약 주식회사 | 파클리탁셀의 가용화용 조성물 및 그의 제조 방법 |
| EP1498120A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Semi-solid formulations for the oral administration of taxoids |
| PT1664033E (pt) | 2003-09-25 | 2008-01-17 | Tapestry Pharmaceuticals Inc | Análogos de 9,1o-a,a-oh-taxanos e processos para sua produção |
| US20060088591A1 (en) * | 2004-10-22 | 2006-04-27 | Jinghua Yuan | Tablets from a poorly compressible substance |
| US20060116420A1 (en) * | 2004-11-23 | 2006-06-01 | Ramakrishnan Chidambaram | Crystalline forms of 3'-tert-Butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxycarbonyl-paclitaxel |
| CA2598213C (en) * | 2005-02-18 | 2011-04-19 | Abraxis Bioscience, Inc. | Drugs with improved hydrophobicity for incorporation in medical devices |
| AU2012202903B2 (en) * | 2005-02-18 | 2014-12-11 | Abraxis Bioscience, Inc. | Drugs with improved hydrophobicity for incorporation in medical devices |
| PL2233156T3 (pl) * | 2005-07-15 | 2013-09-30 | Angiochem Inc | Zastosowanie polipeptydów aprotyninowych jako nośników w koniugatach farmaceutycznych |
| US20070015834A1 (en) * | 2005-07-18 | 2007-01-18 | Moshe Flashner-Barak | Formulations of fenofibrate containing PEG/Poloxamer |
| CA2880727C (en) | 2005-08-31 | 2019-05-07 | Neil P. Desai | Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
| WO2007134354A1 (de) * | 2006-05-23 | 2007-11-29 | Ebewe Pharma Ges.M.B.H. Nfg. Kg | Pharmazeutische formulierung |
| WO2008106621A1 (en) | 2007-02-28 | 2008-09-04 | Tapestry Pharmaceuticals, Inc | Taxane analogs for the treatment of brain cancer |
| US11786504B2 (en) | 2006-09-28 | 2023-10-17 | Tapestry Pharmaceuticals, Inc. | Taxane analogs for the treatment of brain cancer |
| WO2008121476A1 (en) | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| US11873308B2 (en) | 2006-11-06 | 2024-01-16 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| EP1946747A1 (en) * | 2007-01-17 | 2008-07-23 | Sandoz AG | Pharmaceutical composition of improved stability containing taxane derivatives |
| US9089544B2 (en) * | 2007-08-24 | 2015-07-28 | Slotervaart Participaties Bv | Composition |
| KR101544498B1 (ko) * | 2007-08-24 | 2015-08-17 | 스티칭 허트 네덜란드 칸커 인스티튜트 | 종양성 질환의 치료를 위한 조성물 |
| WO2009064681A2 (en) * | 2007-11-12 | 2009-05-22 | Novartis Ag | Liquid compositions comprising valsartan |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| ES2344674B1 (es) | 2008-08-07 | 2011-06-29 | Gp Pharm, S.A. | Composicion farmaceutica inyectable de taxanos. |
| EP2346906A4 (en) | 2008-10-15 | 2013-04-24 | Angiochem Inc | CONJUGATES FROM GLP-1 AGONISTS AND THEIR USE |
| EP2414560B1 (de) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Verfahren zur beschichtung einer oberfläche eines bauteils |
| US9265910B2 (en) | 2009-05-18 | 2016-02-23 | Boehringer Ingelheim International Gmbh | Adapter, inhalation device, and nebulizer |
| CN102038635A (zh) | 2009-10-23 | 2011-05-04 | 天津天士力集团有限公司 | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 |
| EP2504051B1 (en) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Nebulizer |
| CA2781792C (en) | 2009-11-25 | 2019-04-02 | Boehringer Ingelheim International Gmbh | Nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| EP2585151B1 (en) | 2010-06-24 | 2018-04-04 | Boehringer Ingelheim International GmbH | Nebulizer |
| EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| EP2777691A1 (en) * | 2013-03-14 | 2014-09-17 | Pharmachemie B.V. | Taxoid - Purification of Liquid Excipients |
| JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| SG11201608891RA (en) | 2014-05-07 | 2016-11-29 | Boehringer Ingelheim Int | Nebulizer, indicator device and container |
| BR112016023983B1 (pt) | 2014-05-07 | 2022-10-18 | Boehringer Ingelheim International Gmbh | Contentor para um nebulizador, nebulizador para um fluido e método para conectar um contentor a um dispositivo indicador |
| WO2015169430A1 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
| CN103980232A (zh) * | 2014-06-05 | 2014-08-13 | 北京诺普德医药科技有限公司 | 10-乙酰基多西紫杉醇及其用途 |
| CA2989400A1 (en) | 2015-06-15 | 2016-12-22 | Angiochem Inc. | Ang1005 for the treatment of leptomeningeal carcinomatosis |
| TWI752750B (zh) | 2015-09-30 | 2022-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
| CN108066335B (zh) * | 2016-11-11 | 2020-02-21 | 北京康辰药业股份有限公司 | 一种含有紫杉醇或其类似物的药物组合物及其制备方法 |
| FR3113238B1 (fr) | 2020-08-05 | 2024-04-05 | Gattefosse Sas | Utilisation comme excipient, d’un melange de macrogolglyceride laurique et de polyethylene glycol |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US4960790A (en) * | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| US5817321A (en) * | 1992-10-08 | 1998-10-06 | Supratek Pharma, Inc. | Biological agent compositions |
| CA2149150C (en) * | 1992-11-27 | 2000-08-01 | David R. Carver | Injectable taxol composition with improved stability |
| US6395770B1 (en) * | 1995-10-26 | 2002-05-28 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
| US6964946B1 (en) * | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| US6245805B1 (en) * | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| US5977163A (en) * | 1996-03-12 | 1999-11-02 | Pg-Txl Company, L. P. | Water soluble paclitaxel prodrugs |
| US5756537A (en) * | 1996-11-08 | 1998-05-26 | Parkash S. Gill, M.D., Inc. | Regime for paclitaxel in Kaposi's sarcoma patients |
| US6495579B1 (en) * | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| US6515016B2 (en) * | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| US5980936A (en) * | 1997-08-07 | 1999-11-09 | Alliance Pharmaceutical Corp. | Multiple emulsions comprising a hydrophobic continuous phase |
| EP1067923A4 (en) * | 1997-12-31 | 2002-11-13 | Bristol Myers Squibb Co | 2-AROYL-4-ACYL PACLITAXEL (TAXEL) ANALOGS |
| IL131217A0 (en) * | 1998-03-10 | 2001-01-28 | Napro Biotherapeutics Inc | Novel methods and compositions for delivery of taxanes |
| US6979456B1 (en) * | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| JP2002544269A (ja) * | 1999-05-17 | 2002-12-24 | ブリストル−マイヤーズ スクイブ カンパニー | パクリタキセルおよびパクリタキセル類似体の製造におけるシリルエーテルの切断のための新規反応条件 |
| KR100634249B1 (ko) * | 1999-08-11 | 2006-10-17 | 브리스톨-마이어스스퀴브컴파니 | 파클리탁셀 ｃ-4 메틸 카르보네이트 동족체의 제조 방법 |
| US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
| US6916942B2 (en) * | 2000-02-03 | 2005-07-12 | Bristol-Myers Squibb Company | Process for the preparation of C-4 carbonate taxanes |
| US6750246B1 (en) * | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
| TWI310684B (en) * | 2000-03-27 | 2009-06-11 | Bristol Myers Squibb Co | Synergistic pharmaceutical kits for treating cancer |
| US6919370B2 (en) * | 2000-11-28 | 2005-07-19 | Transform Pharmaceuticals, Inc. | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| TWI297335B (en) * | 2001-07-10 | 2008-06-01 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
| AU2002357012A1 (en) * | 2001-11-27 | 2003-06-10 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
-
2002
- 2002-12-12 CA CA002470826A patent/CA2470826A1/en not_active Abandoned
- 2002-12-12 GE GE5614A patent/GEP20063806B/en unknown
- 2002-12-12 AU AU2002361701A patent/AU2002361701A1/en not_active Abandoned
- 2002-12-12 HU HU0500843A patent/HUP0500843A2/hu unknown
- 2002-12-12 HR HR20040545A patent/HRP20040545A2/xx not_active Application Discontinuation
- 2002-12-12 IL IL16211802A patent/IL162118A0/xx unknown
- 2002-12-12 RU RU2004119557/15A patent/RU2004119557A/ru not_active Application Discontinuation
- 2002-12-12 BR BRPI0215184-7A patent/BR0215184A/pt not_active IP Right Cessation
- 2002-12-12 JP JP2003554110A patent/JP2006501134A/ja not_active Withdrawn
- 2002-12-12 RS YU52904A patent/RS52904A/sr unknown
- 2002-12-12 EP EP02797339A patent/EP1465618A2/en not_active Withdrawn
- 2002-12-12 WO PCT/US2002/040127 patent/WO2003053350A2/en not_active Ceased
- 2002-12-12 CN CNB028254708A patent/CN1273130C/zh not_active Expired - Fee Related
- 2002-12-12 PL PL02374283A patent/PL374283A1/xx not_active Application Discontinuation
- 2002-12-12 KR KR10-2004-7009593A patent/KR20040066921A/ko not_active Withdrawn
- 2002-12-16 TW TW091136275A patent/TW200302086A/zh unknown
- 2002-12-19 US US10/323,551 patent/US20030220391A1/en not_active Abandoned
- 2002-12-19 AR ARP020105039A patent/AR037951A1/es unknown
- 2002-12-20 UY UY27598A patent/UY27598A1/es not_active Application Discontinuation
-
2003
- 2003-01-06 PE PE2003000013A patent/PE20030742A1/es not_active Application Discontinuation
-
2004
- 2004-06-09 ZA ZA200404584A patent/ZA200404584B/en unknown
- 2004-06-10 IS IS7306A patent/IS7306A/is unknown
- 2004-06-16 MX MXPA04005877A patent/MXPA04005877A/es unknown
- 2004-07-19 NO NO20043101A patent/NO20043101L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1465618A2 (en) | 2004-10-13 |
| RU2004119557A (ru) | 2005-04-20 |
| KR20040066921A (ko) | 2004-07-27 |
| NO20043101L (no) | 2004-07-19 |
| CA2470826A1 (en) | 2003-07-03 |
| ZA200404584B (en) | 2005-09-13 |
| AU2002361701A1 (en) | 2003-07-09 |
| BR0215184A (pt) | 2006-06-06 |
| HUP0500843A2 (hu) | 2005-12-28 |
| MXPA04005877A (es) | 2004-09-13 |
| WO2003053350A3 (en) | 2004-01-15 |
| RS52904A (sr) | 2006-12-15 |
| JP2006501134A (ja) | 2006-01-12 |
| PL374283A1 (en) | 2005-10-03 |
| AR037951A1 (es) | 2004-12-22 |
| TW200302086A (en) | 2003-08-01 |
| IL162118A0 (en) | 2005-11-20 |
| UY27598A1 (es) | 2003-07-31 |
| CN1273130C (zh) | 2006-09-06 |
| US20030220391A1 (en) | 2003-11-27 |
| HRP20040545A2 (en) | 2005-08-31 |
| WO2003053350A2 (en) | 2003-07-03 |
| GEP20063806B (en) | 2006-04-25 |
| CN1606437A (zh) | 2005-04-13 |
| PE20030742A1 (es) | 2003-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7306A (is) | Lyfjasamsetningar taxanafleiðna, virkar eftir inntöku um munn, og sem eru með aukna líffræðilega virkni | |
| CY2015003I1 (el) | Φαρμακευτικες συνθεσεις για θεραπεια καρκινου | |
| GB0321607D0 (en) | Manufacture of pharmaceutical compositions | |
| IL159725A0 (en) | Pharmaceutical compositions containing benzimidazole derivatives | |
| NO20042739L (no) | Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan | |
| IL164798A0 (en) | Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| HUP0401898A3 (en) | 3-substituted-4-pyrimidone derivatives, pharmaceutical compositions containing them and their intermediates | |
| DK1448195T3 (da) | N-adamantylmethylderivater og mellemprodukter som farmaceutiske præparater og fremgangsmåde til fremstilling deraf | |
| EP1539122A4 (en) | PHARMACEUTICAL AQUEOUS 2,6-DIISOPROPYLPHENOL COMPOSITIONS | |
| HUP0401900A3 (en) | 3-substituted-4-pyrimidone derivatives, pharmaceutical compositions containing them and their intermediates | |
| DK1353668T3 (da) | Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer | |
| IL158898A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF | |
| IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
| IL164896A (en) | Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors | |
| HUP0400850A3 (en) | Oral pharmaceutical compositions | |
| IL166621A0 (en) | Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same | |
| IS7481A (is) | Epóthílon til gjafar um munn | |
| EE200300589A (et) | Ravimkoostised | |
| GB0202900D0 (en) | Novel formulations of drugs | |
| IS7424A (is) | Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær | |
| IL164662A0 (en) | Benzopyranone compounds, compositions thereof, andmethods of treatment therewith | |
| NO20031219D0 (no) | Nye forbindelser avledet fra kinazolin, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| AP2006003613A0 (en) | Oral formulations for 5-HT-receptor agonists, usesand methods of treatment employing the same | |
| ITMI20022358A1 (it) | Composizioni farmaceutiche effervescenti per la realizzazione di sospensioni non convenzionali. | |
| AU2003270202A8 (en) | Pharmaceutical compositions useful for the treatment of cancers |